Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,509 | -4,704 | -11,168 | -8,065 | -5,471 |
| Depreciation Amortization | 295 | 131 | 387 | 283 | 175 |
| Accounts payable and accrued liabilities | 61 | 100 | 229 | 548 | -290 |
| Other Working Capital | -446 | -310 | 2,337 | 2,155 | 961 |
| Other Operating Activity | 2,028 | 1,493 | 693 | 71 | 651 |
| Operating Cash Flow | $-6,571 | $-3,290 | $-7,522 | $-5,008 | $-3,974 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | -16 | -106 | -19 | -10 |
| Net Acquisitions | 934 | 502 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -75 | -54 | -54 |
| Investing Cash Flow | $879 | $486 | $-181 | $-73 | $-64 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,982 | 1,982 | N/A | N/A | 0 |
| Debt Repayment | -108 | -47 | -114 | -74 | -40 |
| Common Stock Issued | 2,288 | 2,047 | 10,768 | 10,633 | 82 |
| Other Financing Activity | 0 | 0 | -773 | -800 | 0 |
| Financing Cash Flow | $4,162 | $3,982 | $9,881 | $9,759 | $42 |
| Beginning Cash Position | 10,174 | 10,174 | 7,996 | 7,996 | 7,996 |
| End Cash Position | 8,644 | 11,352 | 10,174 | 12,674 | 4,000 |
| Net Cash Flow | $-1,530 | $1,178 | $2,178 | $4,678 | $-3,996 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,571 | -3,290 | -7,522 | -5,008 | -3,974 |
| Capital Expenditure | -55 | -16 | -106 | -19 | -10 |
| Free Cash Flow | -6,626 | -3,306 | -7,628 | -5,027 | -3,984 |